Tomas Kalinicik

117PUBLICATIONS
314CO-AUTHORS
Predictive and prognostic markersRural community developmentGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (117)

|Sep 14, 2026
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

|Aug 22, 2026
A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 03, 2026
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

|Jul 29, 2026
Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.

|Jul 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Pageof 20

Frequent Collaborators

44 joint publications

Anneke Van der Walt

38 joint publications

Izanne Roos

22 joint publications

Vilija Jokubaitis

20 joint publications

Michael H Barnett